Pantheon Industries: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
| Line 32: | Line 32: | ||
Today, Pantheon Industries has diversified its portfolio and is still dominant in the pharmaceutical, chemical, and bio-science sectors. The current chairman of Pantheon Industries is Oiksi Iivostner, who was appointed in 2021 after the ousting of the former chairman Bob Dole. | Today, Pantheon Industries has diversified its portfolio and is still dominant in the pharmaceutical, chemical, and bio-science sectors. The current chairman of Pantheon Industries is Oiksi Iivostner, who was appointed in 2021 after the ousting of the former chairman Bob Dole. | ||
== Businesses and investments == | == Businesses and investments == | ||
=== Subsidiaries === | === Subsidiaries === | ||
* [[Katta Seafood]] - Founded in 1887, Katta Seafood traces its origin to the original company that Pantheon was built around. Today, it is one of the largest seafood companies in Caphiria and sells frozen, canned, smoked, and ready-to-eat seafood products for the wholesale, retail and foodservice markets under a variety of different brand names. | |||
* Katta Seafood - Founded in 1887, Katta Seafood traces its origin to the original company that Pantheon was built around. Today, it is one of the largest seafood companies in Caphiria and sells frozen, canned, smoked, and ready-to-eat seafood products for the wholesale, retail and foodservice markets under a variety of different brand names. | |||
* Pharmonis - Founded in 1922, Pharmonis is a pharmaceutical company that mainly operates in the acquisition (for repricing), manufacturing, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients (APIs). In 1983, after concerns about tax evasion and an eventual inquiry from The Imperium, Pharmonis suffered its biggest one-day share price fall in its history. The loss equated equated to half of its market value, at which point Pantheon acquired Pharmonis. Today, the company operates in three segments; Consumer Healthcare, Rx Pharmaceuticals, and Active Pharmaceutical Ingredients. | * Pharmonis - Founded in 1922, Pharmonis is a pharmaceutical company that mainly operates in the acquisition (for repricing), manufacturing, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients (APIs). In 1983, after concerns about tax evasion and an eventual inquiry from The Imperium, Pharmonis suffered its biggest one-day share price fall in its history. The loss equated equated to half of its market value, at which point Pantheon acquired Pharmonis. Today, the company operates in three segments; Consumer Healthcare, Rx Pharmaceuticals, and Active Pharmaceutical Ingredients. | ||
* Lyonardo - Founded in 1978, Lyonardo is a multinational biotechnology company based in Dreistengrad, [[Diamavya]] specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide. Lyonardo owns the rights to Fumaderm and BG-12, an oral fumarate, which is being studied for the treatment of multiple sclerosis and psoriasis.It also owns the patent for a treatment for hemophilia B as well as the technology for developing inhalable treatments. Lyonardo is known for acquiring smaller biotech companies and poaching prominent biologists and has come under scrutiny for these aggressive tactics. It was acquired by Pantheon in 1993 for $3.25 billion. | * Lyonardo - Founded in 1978, Lyonardo is a multinational biotechnology company based in Dreistengrad, [[Diamavya]] specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide. Lyonardo owns the rights to Fumaderm and BG-12, an oral fumarate, which is being studied for the treatment of multiple sclerosis and psoriasis.It also owns the patent for a treatment for hemophilia B as well as the technology for developing inhalable treatments. Lyonardo is known for acquiring smaller biotech companies and poaching prominent biologists and has come under scrutiny for these aggressive tactics. It was acquired by Pantheon in 1993 for $3.25 billion. | ||
| Line 48: | Line 46: | ||
* Dentota - acquired by Pantheon in 2033 for $150 million | * Dentota - acquired by Pantheon in 2033 for $150 million | ||
* Atmios - acquired by Pantheon in 2034 for $11 million | * Atmios - acquired by Pantheon in 2034 for $11 million | ||
=== Investments === | === Investments === | ||
* Pantheon Industries owns 43.4% of [[Elanus]], a highly specialized defense and IT systems manufacturer. Elanus is known for its specialized tracking and data processing units which can be found in anything from security cameras to satellites. It focuses on producing highly specialized products with military applications. | * Pantheon Industries owns 43.4% of [[Elanus]], a highly specialized defense and IT systems manufacturer. Elanus is known for its specialized tracking and data processing units which can be found in anything from security cameras to satellites. It focuses on producing highly specialized products with military applications. | ||
* It maintains a sizeable non-controlling interest in Agroleum Comitat, Compor Mining, Baiereal Petrochemical, and the Marín-Helius Corporation | * It maintains a sizeable non-controlling interest in Agroleum Comitat, Compor Mining, Baiereal Petrochemical, and the Marín-Helius Corporation | ||
| Line 56: | Line 52: | ||
* Pantheon also maintains a 1.4% investment in [[Quicksilver Industries]] | * Pantheon also maintains a 1.4% investment in [[Quicksilver Industries]] | ||
* Pantheon acquired a 5% stake in The Hansa Group | * Pantheon acquired a 5% stake in The Hansa Group | ||
[[category:Caphiria]] | [[category:Caphiria]] | ||
[[category:Companies]] | [[category:Companies]] | ||
[[category:Companies in Caphiria]] | [[category:Companies in Caphiria]] | ||